Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10469 | 995 | 26.7 | 48% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LIVE ATTENUATED INFLUENZA VACCINE | Author keyword | 5 | 23% | 2% | 20 |
2 | LAIV | Author keyword | 4 | 35% | 1% | 9 |
3 | OCULO RESPIRATORY SYNDROME | Author keyword | 3 | 100% | 0% | 3 |
4 | FLUMIST | Author keyword | 3 | 50% | 0% | 4 |
5 | REPEATED VACCINATION | Author keyword | 3 | 60% | 0% | 3 |
6 | VACCINE VIRUS SHEDDING | Author keyword | 3 | 60% | 0% | 3 |
7 | COLD ADAPTED | Author keyword | 2 | 17% | 1% | 12 |
8 | INFLUENZA SEROLOGY | Author keyword | 2 | 67% | 0% | 2 |
9 | MUCOSAL ANTIBODY RESPONSE | Author keyword | 2 | 67% | 0% | 2 |
10 | REASSORTANT INFLUENZA VIRUS | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIVE ATTENUATED INFLUENZA VACCINE | 5 | 23% | 2% | 20 | Search LIVE+ATTENUATED+INFLUENZA+VACCINE | Search LIVE+ATTENUATED+INFLUENZA+VACCINE |
2 | LAIV | 4 | 35% | 1% | 9 | Search LAIV | Search LAIV |
3 | OCULO RESPIRATORY SYNDROME | 3 | 100% | 0% | 3 | Search OCULO+RESPIRATORY+SYNDROME | Search OCULO+RESPIRATORY+SYNDROME |
4 | FLUMIST | 3 | 50% | 0% | 4 | Search FLUMIST | Search FLUMIST |
5 | REPEATED VACCINATION | 3 | 60% | 0% | 3 | Search REPEATED+VACCINATION | Search REPEATED+VACCINATION |
6 | VACCINE VIRUS SHEDDING | 3 | 60% | 0% | 3 | Search VACCINE+VIRUS+SHEDDING | Search VACCINE+VIRUS+SHEDDING |
7 | COLD ADAPTED | 2 | 17% | 1% | 12 | Search COLD+ADAPTED | Search COLD+ADAPTED |
8 | INFLUENZA SEROLOGY | 2 | 67% | 0% | 2 | Search INFLUENZA+SEROLOGY | Search INFLUENZA+SEROLOGY |
9 | MUCOSAL ANTIBODY RESPONSE | 2 | 67% | 0% | 2 | Search MUCOSAL+ANTIBODY+RESPONSE | Search MUCOSAL+ANTIBODY+RESPONSE |
10 | REASSORTANT INFLUENZA VIRUS | 2 | 67% | 0% | 2 | Search REASSORTANT+INFLUENZA+VIRUS | Search REASSORTANT+INFLUENZA+VIRUS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | A VIRUS VACCINES | 44 | 77% | 3% | 30 |
2 | COLD RECOMBINANT | 18 | 83% | 1% | 10 |
3 | COLD ADAPTED INFLUENZA | 15 | 68% | 1% | 13 |
4 | SERONEGATIVE CHILDREN | 15 | 88% | 1% | 7 |
5 | CHRONICALLY ILL ADULTS | 10 | 73% | 1% | 8 |
6 | A ANN ARBOR 6 60 | 10 | 61% | 1% | 11 |
7 | AVIAN HUMAN | 9 | 50% | 1% | 13 |
8 | ATTENUATED INFLUENZA | 8 | 75% | 1% | 6 |
9 | INACTIVATED INFLUENZA | 6 | 47% | 1% | 9 |
10 | REASSORTANT VIRUS | 6 | 43% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Live Attenuated Influenza Vaccine | 2015 | 2 | 63 | 27% |
Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines | 2004 | 266 | 78 | 53% |
Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines | 2002 | 89 | 84 | 79% |
Vaccines for preventing influenza in healthy adults (Review) | 2007 | 71 | 70 | 47% |
Vaccines for preventing influenza in healthy adults | 2010 | 53 | 80 | 45% |
Cold-adapted live attenuated influenza vaccines developed in Russia: Can they contribute to meeting the needs for influenza control in other countries? | 1997 | 42 | 14 | 93% |
Influenza vaccine for patients with chronic obstructive pulmonary disease | 2006 | 61 | 38 | 42% |
Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference | 2011 | 15 | 24 | 54% |
Live attenuated vaccines against influenza; an historical review | 2001 | 42 | 64 | 72% |
Development of live attenuated influenza vaccines against pandemic influenza strains | 2014 | 8 | 46 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT CLIN VIROL | 2 | 67% | 0.2% | 2 |
2 | PEDIAT INFECT DIS P PATHOGENS UNIT | 1 | 100% | 0.2% | 2 |
3 | PRECLIN TRIALS | 1 | 100% | 0.2% | 2 |
4 | SSEPI SEREMI COCHRANE VACCINES FIELD | 1 | 25% | 0.3% | 3 |
5 | ANIMAL SCI TECHNOL | 1 | 50% | 0.1% | 1 |
6 | INDIGENOUS KNOWLEDGE SYST HLTH UNIT | 1 | 50% | 0.1% | 1 |
7 | M NIMBS | 1 | 50% | 0.1% | 1 |
8 | ST VINCENTS CLIN TRIALS | 1 | 50% | 0.1% | 1 |
9 | IMMUNIZAT STUDIES PROGRAM | 1 | 25% | 0.2% | 2 |
10 | JEBSEN INFLUENZA VACCINE | 1 | 22% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000227823 | LIVE ATTENUATED INFLUENZA VACCINE//INFLUENZA VACCINE//INFLUENZA |
2 | 0.0000220312 | AS03//UNIVERSAL VACCINE//HETEROSUBTYPIC IMMUNITY |
3 | 0.0000151791 | VOPROSY VIRUSOLOGII//INFLUENZAVIRUSES//PARAINFLUENZAVIRUSES |
4 | 0.0000117176 | INFLUENZA VACCINATION//INFLUENZA VACCINE//HEALTH CARE WORKERS |
5 | 0.0000101955 | HEMAGGLUTININ//ANTIGENIC DRIFT//D222G |
6 | 0.0000095381 | PB1 F2//INFLUENZA VIRUS//INFLUENZA A VIRUS |
7 | 0.0000090958 | CHAIR BIOPROC ENGN//VACCINE PRODUCTION//RESIDUAL DNA |
8 | 0.0000085706 | DAS181//PARAINFLUENZA//ALBERTA TRANSPLANT SCI |
9 | 0.0000073443 | CHOLERA TOXIN//HEAT LABILE ENTEROTOXIN//RECOMBINANT CHOLERA TOXIN B SUBUNIT RCTB |
10 | 0.0000063798 | ALPHA 1 ANTICHYMOTRYPSIN DEFICIENCY//PULMONARY ADENOCARCINOMA CELL LINE//SERPINE |